Seemant Chaturvedi/LinkedIn
Sep 6, 2025, 13:18
Seemant Chaturvedi: Will Tirofiban Benefit Patients with Acute Ischemic Stroke?
NEJM Journal Watch shared on X:
”Tirofiban as Thrombolysis Adjunct for Patients with Acute Ischemic Stroke
Patients might have benefited from tirofiban, although these findings require confirmation before clinicians change their practice.”
Read the full review here.
Article: Tirofiban as Thrombolysis Adjunct for Patients with Acute Ischemic Stroke
Author: Seemant Chaturvedi
Stay informed on all science in the field of thrombosis with Hemostasis Today.
-
Sep 23, 2026, 11:17High DOAC Adherence After Stroke – International Journal of Stroke
-
Sep 23, 2026, 11:08John Cush: Do JAK Inhibitors Increase VTE Risk After Joint Replacement?
-
Sep 23, 2026, 11:05Fonkou Steve: Blood Choice Requires Access to Safe Transfusion Options
-
Sep 23, 2026, 11:00Linda Rockwood: Cultural and Ethical Change in Transfusion Medicine
-
Sep 23, 2026, 10:30Michael Angers: Advancing Transfusion Safety Through Smarter Laboratory Workflows
-
Sep 23, 2026, 07:28Isabelle Grenier-Pleau: Targeting Von Willebrand Disease to Transform Women’s Health
-
Sep 23, 2026, 07:07Wolfgang Miesbach: Mechanisms of Liver Injury After Hemophilia A Gene Therapy
-
Sep 23, 2026, 06:24Nicolas Gendron: Everolimus and Venous Thromboembolic Risk in Kidney Transplantation
-
Sep 23, 2026, 06:07Hoori Shahwar: Cerebral Venous Sinus Thrombosis Diagnosis and Management